Literature DB >> 15509562

Ser1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms.

Lin Yang1, Guoxia Liu, Sergey I Zakharov, John P Morrow, Vitali O Rybin, Susan F Steinberg, Steven O Marx.   

Abstract

Voltage-dependent Ca(2+) channel (Ca(v)1.2, L-type Ca(2+) channel) function is highly regulated by hormones and neurotransmitters in large part through the activation of kinases and phosphatases. Regulation of Ca(v)1.2 by protein kinase C (PKC) is of significant physiologic importance, mediating, in part, the cardiac response to hormonal regulation. Although PKC has been reported to mediate activation and/or inhibition of Ca(v)1.2 function, the molecular mechanisms mediating the response have not been definitively elucidated. We show that PKC forms a macromolecular complex with the alpha(1c) subunit of Ca(v)1.2 through direct interaction with the C terminus. This interaction leads to phosphorylation of the channel in response to activators of PKC. We identify Ser(1928) as the residue that is phosphorylated by PKC in vitro and in vivo. Ser(1928) has been identified previously as the site mediating, in part, the protein kinase A up-regulation of channel activity. Thus, the protein kinase A and PKC signaling pathways converge on the Ca(v)1.2 complex at Ser(1928) to increase channel activity. Our results identify two mechanisms leading to regulation of Ca(v)1.2 activity by PKC: pre-association of the channel with PKC isoforms and phosphorylation of specific sites within the alpha(1c) subunit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509562     DOI: 10.1074/jbc.M410509200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits.

Authors:  Lin Yang; Alexander Katchman; John P Morrow; Darshan Doshi; Steven O Marx
Journal:  FASEB J       Date:  2010-12-02       Impact factor: 5.191

Review 2.  The ß subunit of voltage-gated Ca2+ channels.

Authors:  Zafir Buraei; Jian Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  Protein kinase C mechanisms that contribute to cardiac remodelling.

Authors:  Alexandra C Newton; Corina E Antal; Susan F Steinberg
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

4.  Beta-adrenergic stimulation of L-type Ca2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928.

Authors:  Anand N Ganesan; Christoph Maack; David C Johns; Agnieszka Sidor; Brian O'Rourke
Journal:  Circ Res       Date:  2006-01-05       Impact factor: 17.367

Review 5.  Supramolecular assemblies and localized regulation of voltage-gated ion channels.

Authors:  Shuiping Dai; Duane D Hall; Johannes W Hell
Journal:  Physiol Rev       Date:  2009-04       Impact factor: 37.312

Review 6.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 7.  Spinal and afferent PKC signaling mechanisms that mediate chronic pain in sickle cell disease.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Neurosci Lett       Date:  2019-04-30       Impact factor: 3.046

8.  Phosphorylation of the consensus sites of protein kinase A on alpha1D L-type calcium channel.

Authors:  Omar Ramadan; Yongxia Qu; Raj Wadgaonkar; Ghayath Baroudi; Eddy Karnabi; Mohamed Chahine; Mohamed Boutjdir
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

9.  Protein kinase C enhances plasma membrane expression of cardiac L-type calcium channel, CaV1.2.

Authors:  Tal Keren Raifman; Prabodh Kumar; Hannelore Haase; Enno Klussmann; Nathan Dascal; Sharon Weiss
Journal:  Channels (Austin)       Date:  2017-09-21       Impact factor: 2.581

Review 10.  Redox regulation of sodium and calcium handling.

Authors:  Stefan Wagner; Adam G Rokita; Mark E Anderson; Lars S Maier
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.